Real‐world effectiveness of 8‐week glecaprevir/pibrentasvir (G/P) for treatment naive, noncirrhotic patients with HCV infection in the TRIO network-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real‐world effectiveness of 8‐week glecaprevir/pibrentasvir (G/P) for treatment naive, noncirrhotic patients with HCV infection in the TRIO network

Published:2020-03 Issue:2 Volume:2 Page:64-71
ISSN:1478-1239
Container-title:GastroHep
language:en
Short-container-title:GastroHep

Author:

Curry Michael P.¹^ORCID,Kort Jens²,Marx Steve²,Strezewski John²,Wick Nicole³^ORCID,Flamm Steven L.⁴,Bacon Bruce⁵,Tsai Naoky⁶

Affiliation:

1. Beth Israel Deaconess Medical Center Boston MA USA

2. AbbVie North Chicago IL USA

3. Trio Health Analytics La Jolla CA USA

4. Northwestern University Feinberg School of Medicine Chicago IL USA

5. Saint Louis University School of Medicine St. Louis MO USA

6. University of Hawaii Honolulu HI USA

Funder

AbbVie

Publisher

Hindawi Limited

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ygh2.388

Reference30 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Epidemiology and natural history of HCV infection

3. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

4. Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013

5. The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP